{"meta":{"query_hash":"41558b7674d1","filters":{"venue":"Pharmaceutical Patent Analyst"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/41558b7674d1","api":"https://metacan.xera.ac/api/v1/cohort?venue=Pharmaceutical+Patent+Analyst"},"results":[{"id":"W1997836420","doi":"10.4155/ppa.12.62","title":"The patent-regulatory Regime in Canada","year":2012,"lang":"en","type":"article","venue":"Pharmaceutical Patent Analyst","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's and Gender Studies et Recherches Féministes","funders":"","keywords":"Notice; Political science; Economic Justice; Food and drug administration; Orphan drug; Business; Library science; Law; Medicine; Biology; Pharmacology; Computer science; Bioinformatics","score_opus":0.253747303083136,"score_gpt":0.26827586577306856,"score_spread":0.014528562689932578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997836420","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33078182,0.018002436,0.0017936219,0.15252088,0.0013937864,0.0003373978,0.0023914776,0.00028901247,0.4924896],"genre_scores_gemma":[0.8305763,0.0043070517,0.0013398506,0.02478058,0.0003069876,0.00007507431,0.00029957382,0.00010542349,0.13820913],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885394,0.0006746719,0.00040375942,0.0010886263,0.003886347,0.0054072747],"domain_scores_gemma":[0.98326164,0.0037051407,0.0009798331,0.00045757226,0.0076341983,0.0039617713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004858531,0.00038115037,0.0010037319,0.003842584,0.02251823,0.015336453,0.0026810265,0.008904438,0.011189695],"category_scores_gemma":[0.019175356,0.0010055988,0.0010497656,0.005549435,0.005901978,0.0029257203,0.0027698039,0.008272987,0.00048740464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030348322,0.00020348937,0.017575925,0.00025240032,0.00013588837,0.0012025891,0.0035005722,0.002774789,0.0014100332,0.83728796,0.08852308,0.046829816],"study_design_scores_gemma":[0.00037749112,0.00016507856,0.15277056,0.00070500147,0.00028647954,0.0003095664,0.006765839,0.006530388,0.0020719722,0.043466836,0.78596836,0.00058236026],"about_ca_topic_score_codex":0.9973941,"about_ca_topic_score_gemma":0.99883467,"teacher_disagreement_score":0.7455971,"about_ca_system_score_codex":0.25440285,"about_ca_system_score_gemma":0.3623911,"threshold_uncertainty_score":0.864787},"labels":[],"label_agreement":null},{"id":"W2064679735","doi":"10.4155/ppa.14.39","title":"Inhibitors of voltage-gated Sodium Channel Na <sub>v</sub> 1.7: Patent Applications Since 2010","year":2014,"lang":"en","type":"review","venue":"Pharmaceutical Patent Analyst","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Sodium channel; Chemistry; Sodium; Nanotechnology; Materials science; Organic chemistry","score_opus":0.09180525462218428,"score_gpt":0.3306597990516639,"score_spread":0.23885454442947965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064679735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000755628,0.99373144,0.0005125968,0.00035602038,0.00023345325,0.000017155577,0.00009353117,0.000029209681,0.004270884],"genre_scores_gemma":[0.002900861,0.9935782,0.00046468756,0.0002647147,0.00014887689,0.000019037803,0.000105778636,0.000003837413,0.002514045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986506,0.000012492679,0.000014829765,0.000029398525,0.00005976322,0.000018557266],"domain_scores_gemma":[0.99985075,0.00005482095,0.00003418269,0.0000041369835,0.00003732173,0.000018772807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003479699,0.0007888279,0.00097419,0.0018097112,0.00023395597,0.00063916703,0.0005862388,0.00060694746,0.0053647486],"category_scores_gemma":[0.00043954828,0.00019196431,0.00045583834,0.001872659,0.00033683155,0.0010594977,0.00044889073,0.0010666858,0.0031513176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008075093,0.00008188602,0.00012987643,0.01143341,0.000060061724,0.00027464938,0.000045966673,0.00033751247,0.0081397155,0.003506565,0.026518445,0.9493912],"study_design_scores_gemma":[0.00003055504,0.00021257572,0.0007967801,0.0014226639,0.00012824095,0.0012793295,0.000032268486,0.000088206914,0.0029442755,0.0013563598,0.9916899,0.000018784653],"about_ca_topic_score_codex":0.00037078033,"about_ca_topic_score_gemma":0.0009476732,"teacher_disagreement_score":0.0053647486,"about_ca_system_score_codex":0.0004561528,"about_ca_system_score_gemma":0.00058230833,"threshold_uncertainty_score":0.01794684},"labels":[],"label_agreement":null},{"id":"W2092351901","doi":"10.4155/ppa.12.45","title":"Differentiating Stem Cell Patents","year":2012,"lang":"en","type":"review","venue":"Pharmaceutical Patent Analyst","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"","keywords":"Stem cell; Embryonic stem cell; Induced pluripotent stem cell; Patentability; Regenerative medicine; Biology; Cell biology; Adult stem cell; Patent law; Genetics; Computer science; Intellectual property","score_opus":0.232632293917567,"score_gpt":0.393937842891255,"score_spread":0.16130554897368798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092351901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015119558,0.8525456,0.004628862,0.0024858792,0.003191386,0.000117929965,0.00032390066,0.00011139985,0.13508311],"genre_scores_gemma":[0.011249945,0.90969974,0.0040535466,0.002685237,0.0017506721,0.00009122024,0.0007850897,0.000034267247,0.069650345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950075,0.000050438008,0.00005216877,0.000080065874,0.00027453664,0.000042021653],"domain_scores_gemma":[0.99960893,0.00015928142,0.000051426257,0.000028992064,0.000107440035,0.000043796626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010531477,0.0007606173,0.00068141526,0.0020546117,0.00051428704,0.0014452299,0.0010306289,0.0016211075,0.018035807],"category_scores_gemma":[0.0012709087,0.00025098328,0.00046286624,0.0016987878,0.0008281151,0.0020188775,0.001064378,0.0016406556,0.011187534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028048833,0.000041777574,0.00012103659,0.0029899674,0.000013210167,0.00039747765,0.00007788222,0.00016932203,0.0047956826,0.031556234,0.051117077,0.90869224],"study_design_scores_gemma":[0.000004878687,0.000015182931,0.00011804914,0.00042737933,0.0000061818,0.0005158931,0.0000142231775,0.000024695031,0.0013922687,0.0030865774,0.9943903,0.00000434968],"about_ca_topic_score_codex":0.0006100755,"about_ca_topic_score_gemma":0.0009299257,"teacher_disagreement_score":0.018035807,"about_ca_system_score_codex":0.0008621805,"about_ca_system_score_gemma":0.0010870177,"threshold_uncertainty_score":0.060335755},"labels":[],"label_agreement":null},{"id":"W2165246524","doi":"10.4155/ppa.14.31","title":"Advances and Strategies in NADPH Oxidase Inhibitors and Activators Patents","year":2014,"lang":"en","type":"review","venue":"Pharmaceutical Patent Analyst","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hyperion Technologies (Canada)","funders":"","keywords":"NADPH oxidase; NOx; Enzyme; Reactive oxygen species; Biochemistry; Chemistry; Pharmacology; Biology; Computational biology","score_opus":0.0789722978028615,"score_gpt":0.3555411628673972,"score_spread":0.2765688650645357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165246524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047686262,0.993159,0.0004761478,0.0007190416,0.000504988,0.000022411026,0.00006268974,0.00002280232,0.0045561367],"genre_scores_gemma":[0.003484409,0.99120224,0.0007068972,0.0006769784,0.00059324614,0.000032028307,0.00012234226,0.000005997876,0.003175822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999589,0.00006024042,0.000045475543,0.00007518758,0.00018517915,0.000044862314],"domain_scores_gemma":[0.99968815,0.00014380385,0.0000508863,0.000012227325,0.000077296696,0.000027585782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093899417,0.0009393239,0.001049901,0.0029878602,0.00032134925,0.0013052872,0.001122954,0.0011449788,0.0074361297],"category_scores_gemma":[0.0010671121,0.00033769794,0.0009278919,0.0020342467,0.00042208098,0.0018395004,0.0007247004,0.0026263276,0.0034849013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001148524,0.0001969212,0.00017777782,0.010856598,0.00008807634,0.00058287825,0.00010005268,0.00049957994,0.0045758034,0.013717864,0.036883455,0.93220603],"study_design_scores_gemma":[0.000024922652,0.0001289267,0.00030196688,0.0015672074,0.00006015109,0.0010807416,0.000026925052,0.000091407805,0.0010435142,0.0021773858,0.9934829,0.000014014474],"about_ca_topic_score_codex":0.0006123477,"about_ca_topic_score_gemma":0.0010274897,"teacher_disagreement_score":0.0074361297,"about_ca_system_score_codex":0.0007350946,"about_ca_system_score_gemma":0.00085266214,"threshold_uncertainty_score":0.024876297},"labels":[],"label_agreement":null},{"id":"W2274414307","doi":"10.4155/ppa-2016-0001","title":"Biologics and Biosimilars: a Legal Perspective From Canada","year":2016,"lang":"en","type":"editorial","venue":"Pharmaceutical Patent Analyst","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Library science; Christian ministry; Family medicine; Political science; Internal medicine; Law; Computer science","score_opus":0.04711475273903797,"score_gpt":0.33904405110552555,"score_spread":0.29192929836648757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274414307","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007109575,0.040691152,0.00014468568,0.27298597,0.6818115,0.000016999973,0.00006422733,0.000031077092,0.0041833417],"genre_scores_gemma":[0.002133244,0.032946877,0.00025010877,0.17854324,0.76417077,0.000022781189,0.00003834906,0.00006382851,0.021830777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9782752,0.0018959863,0.0023317337,0.0014209329,0.014429454,0.0016467273],"domain_scores_gemma":[0.9324308,0.026351254,0.0033023537,0.0011352941,0.030169416,0.006610845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017264996,0.0031533737,0.0040887883,0.006411347,0.007971364,0.020430839,0.007138449,0.06474262,0.0057692216],"category_scores_gemma":[0.05477274,0.0019316752,0.0035545724,0.0042389114,0.008526015,0.0075508673,0.0031540615,0.056620147,0.0026292508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015657884,0.000009046649,0.000018428624,0.00013658308,0.00001650791,0.00014190681,0.00003917999,0.000034588847,0.000027733005,0.0013430542,0.99410963,0.0041076965],"study_design_scores_gemma":[0.000040424417,0.000009197475,0.00019198228,0.00067661016,0.0000556059,0.00015946748,0.00009305338,0.000098793855,0.0000626068,0.0018762008,0.9967038,0.00003226741],"about_ca_topic_score_codex":0.19856517,"about_ca_topic_score_gemma":0.40821204,"teacher_disagreement_score":0.8014348,"about_ca_system_score_codex":0.030007727,"about_ca_system_score_gemma":0.051025562,"threshold_uncertainty_score":0.39481884},"labels":[],"label_agreement":null},{"id":"W2771876169","doi":"10.4155/ppa-2017-0038","title":"Canada's Supreme Court Abolishes ‘promise of the patent’","year":2017,"lang":"en","type":"article","venue":"Pharmaceutical Patent Analyst","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"World Wildlife Fund Canada","funders":"","keywords":"Supreme court; Doctrine; Law; Subject matter; Statutory law; Certainty; Supreme Court Decisions; Political science; Patent law; Law and economics; Economics; Intellectual property; Philosophy","score_opus":0.27371656525676563,"score_gpt":0.28500588786895853,"score_spread":0.011289322612192898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771876169","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023060216,0.003720308,0.005184217,0.17362475,0.0024991524,0.00013256566,0.0017370905,0.00038913713,0.78965265],"genre_scores_gemma":[0.5187576,0.003749855,0.0065739797,0.1726548,0.0012492872,0.00012611921,0.000945592,0.00023381975,0.29570892],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98338807,0.00071391545,0.00047682706,0.0012524022,0.010196422,0.0039723995],"domain_scores_gemma":[0.9853241,0.004096523,0.00036030926,0.0007034483,0.0085576875,0.0009578796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006741824,0.00049486547,0.0007902959,0.001737255,0.019642126,0.010771883,0.0028139371,0.011963831,0.0073217563],"category_scores_gemma":[0.02169163,0.00073804654,0.001204155,0.0023681205,0.008797822,0.0026589027,0.002785777,0.014703786,0.0011493487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032756903,0.000013788561,0.0009968488,0.000041554384,0.000019748733,0.00026791496,0.0013302902,0.00019350873,0.00049621525,0.8196756,0.16829488,0.008636767],"study_design_scores_gemma":[0.000066688095,0.000031220156,0.0035363985,0.00018825146,0.00010335171,0.00014320297,0.0007724543,0.0009344688,0.0014752507,0.04956051,0.94304514,0.00014316215],"about_ca_topic_score_codex":0.9656434,"about_ca_topic_score_gemma":0.981385,"teacher_disagreement_score":0.05279268,"about_ca_system_score_codex":0.05279268,"about_ca_system_score_gemma":0.18073946,"threshold_uncertainty_score":0.38303953},"labels":[],"label_agreement":null},{"id":"W2911140943","doi":"10.4155/ppa-2018-0024","title":"Discussions on the New Molecular Formula and New Molecular Entity Definitions of Pharmaceutical Innovation","year":2018,"lang":"en","type":"article","venue":"Pharmaceutical Patent Analyst","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"MEDLINE; Medicine; Library science; Computer science; Political science","score_opus":0.27535559192031356,"score_gpt":0.35251569796290894,"score_spread":0.07716010604259538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911140943","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013540457,0.03618046,0.061632685,0.63399124,0.015924573,0.00011491115,0.00033071745,0.0000731436,0.2382118],"genre_scores_gemma":[0.5696867,0.026783956,0.05624287,0.22667366,0.058076676,0.00089011545,0.00029104698,0.00036281743,0.060992222],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9793411,0.01067943,0.0014369804,0.0019653114,0.0053802426,0.0011968422],"domain_scores_gemma":[0.96783227,0.024592353,0.0023027898,0.0017782645,0.0027987557,0.0006955218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028158376,0.0009959509,0.0015223541,0.0036109863,0.003879255,0.011061817,0.0051560877,0.016485259,0.009310413],"category_scores_gemma":[0.035501596,0.00080093916,0.0020430214,0.003593717,0.027463935,0.031561207,0.004330279,0.026208695,0.0010159009],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034339232,0.000002520471,0.000012027673,0.00001368611,0.0000011198035,0.0000060607176,0.00011775879,0.000036194255,0.000019974874,0.99722207,0.0018003612,0.0007648299],"study_design_scores_gemma":[0.000018342238,0.00001477143,0.00019648994,0.0001608299,0.000009335621,0.00006417616,0.0002636369,0.00054259365,0.00024086854,0.90073675,0.09772687,0.000025247824],"about_ca_topic_score_codex":0.0015776752,"about_ca_topic_score_gemma":0.0017372725,"teacher_disagreement_score":0.028158376,"about_ca_system_score_codex":0.0076432293,"about_ca_system_score_gemma":0.0027332392,"threshold_uncertainty_score":0.14891756},"labels":[],"label_agreement":null},{"id":"W4220679694","doi":"10.4155/ppa-2021-0027","title":"Baicalein: Promising Therapeutic Applications With Special Reference to Published Patents","year":2022,"lang":"en","type":"review","venue":"Pharmaceutical Patent Analyst","topic":"Flavonoids in Medical Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Baicalein; Scutellaria baicalensis; Pharmacology; Medicine; Traditional medicine; Traditional Chinese medicine; Pathology","score_opus":0.4173883201346984,"score_gpt":0.48348445466439033,"score_spread":0.06609613452969193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220679694","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011404757,0.98213124,0.0004352542,0.000571538,0.00052348734,0.000037695656,0.0003124449,0.000034881337,0.014812909],"genre_scores_gemma":[0.0067314226,0.98317045,0.0008029044,0.00044648533,0.0005828478,0.000025232905,0.00048954325,0.000009908885,0.0077412324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998789,0.000012526771,0.0000150313645,0.000026379834,0.000053250224,0.000013956255],"domain_scores_gemma":[0.9998878,0.00004045509,0.000028255487,0.0000044050807,0.00002626114,0.000012847733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023757025,0.0007101772,0.0006760938,0.003401476,0.0002941963,0.0008731971,0.00038796067,0.00055700284,0.017029226],"category_scores_gemma":[0.00036526623,0.00013904403,0.0005050799,0.0030483855,0.00023583163,0.0009425931,0.00039566908,0.0008933359,0.0041548647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007382481,0.00009029114,0.00020078232,0.01607213,0.00006332802,0.00055042404,0.000079620426,0.0002523921,0.013130483,0.00628992,0.044720232,0.9184766],"study_design_scores_gemma":[0.00001325981,0.00007982836,0.00065252476,0.0010916203,0.00006066018,0.0010096517,0.000023490946,0.000054391454,0.0014772947,0.0010983789,0.9944272,0.000011879863],"about_ca_topic_score_codex":0.00073088176,"about_ca_topic_score_gemma":0.0017219917,"teacher_disagreement_score":0.017029226,"about_ca_system_score_codex":0.00037563298,"about_ca_system_score_gemma":0.00065752864,"threshold_uncertainty_score":0.05696845},"labels":[],"label_agreement":null}]}